Xavier Scott, PhD, is a seasoned medical and regulatory affairs writer with expertise in clinical research, regulatory documentation, and medical communications. With advanced training in applied data science and a PhD in physiology, he brings scientific rigor and regulatory insight to the pharmaceutical and biotech sectors. Xavier has hands-on experience with clinical study protocols, investigator brochures, IND/NDA modules, and clinical study reports, ensuring compliance with ICH, FDA, and EMA guidelines. He also supports medical affairs by preparing medical information letters, scientific response documents, and MSL materials. As Vice-Chair of Communications for Houston RAPS LNG and a certified regulatory writer, Xavier focuses on first-in-human trials, oncology, cardiovascular disease, and CNS disorders, driving better patient outcomes through evidence-based communication.